RVPH
REVIVA PHARMACEUTICALS HOLDINGS, INC.
Key Financials
Net Income
$-19864902
↑ 33.6%
Operating Income
$-20200031
↑ 34.4%
Total Assets
$15.9M
↑ 2.7%
Shareholders' Equity
$8.6M
↑ 964.2%
Cash & Equivalents
$14.4M
↑ 7.1%
Total Liabilities
$7.3M
↓ 50.5%
Operating Cash Flow
$-24594643.00
↑ 26.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| SCHEDULE 13G | 5/14/2026 | View on SEC |
| 10-Q | 5/13/2026 | View on SEC |
| 8-K | 5/13/2026 | View on SEC |
| 8-K | 5/13/2026 | View on SEC |
| SCHEDULE 13G | 5/7/2026 | View on SEC |
| 8-K | 4/15/2026 | View on SEC |
| SCHEDULE 13G | 3/30/2026 | View on SEC |
| S-8 | 3/30/2026 | View on SEC |
| 8-K | 3/30/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | RVPH |
| Company Name | REVIVA PHARMACEUTICALS HOLDINGS, INC. |
| CIK | 1742927 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 4085018881 |